Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder
NCT00203528Phase 4Completed
- Sponsor
- Tuscaloosa Research and Education Advancement Corporation
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of divalproex sodium in bipolar disorder (BD), substance use disorder (SUD), sponsored by Tuscaloosa Research and Education Advancement Corporation. Started Jan 2004; status: completed.
02
Drugs
divalproex sodium
03
Conditions
bipolar disorder (BD)substance use disorder (SUD)
Beyond the preview
Go deeper on NCT00203528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00203528.